by Mike Arnold Prior to the release of any new drug, there is always a measure of uncertainty regarding both its efficacy and safety in the target population. This is particularly true of those drugs being sold specifically for off-label use in conjunction with untested dosing recommendations and/or methods of administration. Upon its release, Ostarine
Read More...
Read More...
